These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 17493381)

  • 41. [Clinical significance of bcl-2 protein expression and classification algorithm in diffuse large B-cell lymphoma].
    Li M; Liu CL; Wang XY; Xue XM; Gao ZF
    Zhonghua Bing Li Xue Za Zhi; 2012 Dec; 41(12):813-7. PubMed ID: 23324229
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD10 antigen expression correlates with the t(14;18)(q32;q21) major breakpoint region in diffuse large B-cell lymphoma.
    Fang JM; Finn WG; Hussong JW; Goolsby CL; Cubbon AR; Variakojis D
    Mod Pathol; 1999 Mar; 12(3):295-300. PubMed ID: 10102615
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Primary cutaneous diffuse large B-cell lymphoma, leg type: a study of clinicopathology, immunophenotype and gene rearrangement].
    Wang T; Jia L; Liao W; Chen L; Chen X; Xiong Y; Hao F; Zhu X; Yang X; Wang L
    Zhonghua Bing Li Xue Za Zhi; 2015 Feb; 44(2):100-5. PubMed ID: 25916640
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mutations of the 5' noncoding region of the BCL-6 gene in primary bone lymphomas.
    Gianelli U; Ponzoni M; Moro A; Alfano RM; Pellegrini C; Giardini R; Patriarca C; Armiraglio E; Bosari S; Parafioriti A; Coggi G
    Ann Hematol; 2003 Nov; 82(11):691-5. PubMed ID: 14513282
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pathogenetic and clinical implications of Bcl-6 and Bcl-2 gene configuration in nodal diffuse large B-cell lymphomas.
    Pescarmona E; De Sanctis V; Pistilli A; Pacchiarotti A; Martelli M; Guglielmi C; Mandelli F; Baroni CD; Le Coco F
    J Pathol; 1997 Nov; 183(3):281-6. PubMed ID: 9422982
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma.
    Gascoyne RD; Adomat SA; Krajewski S; Krajewska M; Horsman DE; Tolcher AW; O'Reilly SE; Hoskins P; Coldman AJ; Reed JC; Connors JM
    Blood; 1997 Jul; 90(1):244-51. PubMed ID: 9207459
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinicopathologic and immunohistochemical study of primary non-Hodgkin lymphoma of the female genital system].
    Jiang XF; Yang KX; Peng ZL; Xu L; Huang Q; Li Q
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):222-6. PubMed ID: 17631759
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diffuse large B-cell lymphoma in the spinal epidural space: A study of the Osaka Lymphoma Study Group.
    Wada N; Kohara M; Ikeda J; Hori Y; Fujita S; Okada M; Ogawa H; Sugiyama H; Fukuhara S; Kanamaru A; Hino M; Kanakura Y; Morii E; Aozasa K
    Pathol Res Pract; 2010 Jul; 206(7):439-44. PubMed ID: 20399024
    [TBL] [Abstract][Full Text] [Related]  

  • 49. T-cell leukemia 1 expression in nodal Epstein-Barr virus-negative diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma.
    Gualco G; Weiss LM; Barber GN; Bacchi CE
    Hum Pathol; 2010 Sep; 41(9):1238-44. PubMed ID: 20382409
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Factors affecting the prognosis of diffuse large B-cell lymphoma in Chinese].
    Weng Y; Gao ZF; Liu K; Zhang WJ; Ke XY; Li M
    Zhonghua Nei Ke Za Zhi; 2005 Sep; 44(9):681-3. PubMed ID: 16202261
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Significance of MUM-1/IRF4 protein expression in follicular lymphoma].
    Huo YY; Pan Y; Guan BX; Fang AJ; Sun BC; Zhou GY; Fu K; Meng B
    Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):528-31. PubMed ID: 22169641
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of the Prognostic Importance of c-Myc and Bcl-2 Expressions and the Presence of Epstein-Barr Virus in Classical Hodgkin Lymphoma.
    Kiliçarslan A; Öztürk V; Yikilmaz AŞ; Doğan M; Akyol M
    Turk Patoloji Derg; 2018; 34(3):199-206. PubMed ID: 29708579
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sporadic Burkitt lymphoma in southern China: 12 years' experience in a single institution in Guangzhou.
    Ye Z; Xiao Y; Shi H; Ke Z; Liu Y; Liang Y; Han A
    J Clin Pathol; 2011 Dec; 64(12):1132-5. PubMed ID: 21653657
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incidence of single hit Bcl-2 and Bcl-6 rearrangements in DLBCL: the Irish experience.
    Dinneen K; Timlin DM; O'Hare K; Walker J; Castriciano G; Connolly Y; Grant C; Bacon L; Vandenberghe E; Dunne B; Jeffers M; Flavin R
    J Clin Pathol; 2020 Oct; 73(10):689-690. PubMed ID: 32680911
    [No Abstract]   [Full Text] [Related]  

  • 55. [Analysis of mutations in IgVH genes in diffuse large B-cell lymphomas].
    Liang Y; Zhou R; Zhang W; Zhang HL; Xu HD; Mao ZR
    Zhonghua Bing Li Xue Za Zhi; 2007 Sep; 36(9):625-6. PubMed ID: 18070454
    [No Abstract]   [Full Text] [Related]  

  • 56. Advances in Pathobiology of Primary Central Nervous System Lymphoma.
    Yang XL; Liu YB
    Chin Med J (Engl); 2017 Aug; 130(16):1973-1979. PubMed ID: 28776551
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An unusual presentation of large B-cell lymphoma with interferon regulatory factor 4 gene rearrangement.
    Verma A; Epari S; Gujral S; Shet T
    Indian J Pathol Microbiol; 2018; 61(2):271-274. PubMed ID: 29676376
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Primary cutaneous large B-cell lymphomas: clinicopathologic features, classification, and prognostic factors in a large series of patients.
    Kodama K; Massone C; Chott A; Metze D; Kerl H; Cerroni L
    Blood; 2005 Oct; 106(7):2491-7. PubMed ID: 15947086
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pathologic prognostic factors in diffuse aggressive non-Hodgkin's lymphoma.
    Gascoyne RD
    Hematol Oncol Clin North Am; 1997 Oct; 11(5):847-62. PubMed ID: 9336718
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunohistochemical double hit score enhances NCCN-IPI and is associated with detrimental outcomes in refractory or relapsing patients with diffuse large B cell lymphoma.
    Prochazka KT; Posch F; Deutsch A; Beham-Schmid C; Stöger H; Abdyli L; Greinix H; Pichler M; Neumeister P
    Br J Haematol; 2018 Oct; 183(1):142-146. PubMed ID: 28875547
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.